FY2027 EPS Estimates for Doximity Raised by Leerink Partnrs

Doximity, Inc. (NASDAQ:DOCS) – Equities research analysts at Leerink Partnrs increased their FY2027 earnings per share (EPS) estimates for shares of Doximity in a research note issued on Monday, March 3rd. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings per share of $1.33 for the year, up from their previous estimate of $1.31. Leerink Partnrs currently has a “Strong-Buy” rating on the stock. The consensus estimate for Doximity’s current full-year earnings is $0.99 per share. Leerink Partnrs also issued estimates for Doximity’s FY2028 earnings at $1.47 EPS.

Other equities analysts also recently issued research reports about the stock. Wells Fargo & Company restated an “equal weight” rating on shares of Doximity in a research report on Friday, February 7th. The Goldman Sachs Group raised their price objective on shares of Doximity from $58.00 to $80.00 and gave the company a “neutral” rating in a research report on Monday, February 10th. Bank of America boosted their target price on Doximity from $54.00 to $57.00 and gave the stock a “neutral” rating in a research report on Monday, January 6th. Morgan Stanley upgraded Doximity from an “underweight” rating to an “equal weight” rating and lifted their price target for the company from $33.00 to $53.00 in a research note on Thursday, November 14th. Finally, Stephens began coverage on Doximity in a research report on Friday, December 20th. They issued an “equal weight” rating and a $55.00 price objective for the company. Eleven equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, Doximity presently has an average rating of “Moderate Buy” and a consensus target price of $64.22.

Doximity Price Performance

Shares of NASDAQ DOCS opened at $68.22 on Tuesday. The stock has a fifty day moving average price of $62.11 and a 200 day moving average price of $50.95. Doximity has a 1-year low of $22.96 and a 1-year high of $85.21. The company has a market cap of $12.74 billion, a PE ratio of 68.22, a P/E/G ratio of 4.10 and a beta of 1.39.

Hedge Funds Weigh In On Doximity

A number of institutional investors have recently modified their holdings of DOCS. B. Riley Wealth Advisors Inc. acquired a new position in Doximity in the 4th quarter valued at $326,000. American Trust grew its position in shares of Doximity by 33.2% in the fourth quarter. American Trust now owns 7,540 shares of the company’s stock valued at $403,000 after purchasing an additional 1,880 shares during the period. Mackenzie Financial Corp acquired a new position in Doximity in the fourth quarter valued at $7,144,000. Cache Advisors LLC purchased a new position in Doximity during the fourth quarter worth about $753,000. Finally, Tidal Investments LLC acquired a new stake in Doximity in the 4th quarter worth about $246,000. Institutional investors and hedge funds own 87.19% of the company’s stock.

Insider Buying and Selling

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the company’s stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the transaction, the director now directly owns 6,360 shares in the company, valued at approximately $366,463.20. This represents a 75.87 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 37.40% of the stock is currently owned by company insiders.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.